Rheumatoid arthritis is treated with medications that slow or stop the immune system from attacking your joints, combined with strategies to manage pain and protect joint function. The most important factor in treatment is timing: research in two large patient cohorts found that the window of opportunity for achieving drug-free remission starts to close just 13 to 19 weeks after symptoms begin. Starting treatment early gives you the best chance of preventing permanent joint damage.
Why Early Treatment Matters
Rheumatoid arthritis (RA) isn’t just joint pain. Your immune system is actively eroding cartilage and bone, and that damage is irreversible. The goal of modern treatment is remission, meaning the disease is essentially quiet, with no ongoing inflammation or joint destruction. Getting there depends heavily on how quickly you begin medication after symptoms appear.
A study across two early RA cohorts found that the chance of achieving sustained, drug-free remission dropped significantly after about 14 to 15 weeks of symptom duration. That’s roughly three and a half months. Waiting longer doesn’t just delay relief; it narrows what treatment can ultimately accomplish. This is why rheumatologists push to start medication as soon as a diagnosis is confirmed, sometimes even before all test results are back.
The First Medication You’ll Likely Take
Methotrexate is the cornerstone of RA treatment and typically the first drug prescribed. It works by dialing down your overactive immune response, reducing the inflammation that causes joint swelling, stiffness, and damage. The standard starting dose is 7.5 mg taken once a week, not daily, which your doctor adjusts over time based on how you respond.
Methotrexate belongs to a class called conventional DMARDs (disease-modifying antirheumatic drugs). Unlike painkillers, which only mask symptoms, DMARDs target the underlying disease process. The tradeoff is that they take time to work, often several weeks to a few months before you notice a real difference. Common side effects include nausea, mouth sores, stomach discomfort, and hair thinning. Your doctor will monitor your blood work regularly to watch for effects on your liver and blood cell counts.
Most people also take folic acid alongside methotrexate to reduce side effects. If methotrexate alone doesn’t bring the disease under control, other conventional DMARDs can be added to the regimen.
Bridging the Gap With Steroids
Because DMARDs take weeks to months to kick in, many people need something to control inflammation in the meantime. Low-dose corticosteroids, typically less than 7.5 mg per day of prednisolone, serve as a bridge during this waiting period. They reduce swelling and pain quickly, often within days.
This bridging therapy is meant to be short. Guidelines recommend tapering off steroids within two to three months, and no longer than six months. Long-term steroid use carries serious risks including bone thinning, weight gain, and increased infection susceptibility, so the aim is always to get off them as soon as your DMARD takes effect.
Biologics and Targeted Therapies
If conventional DMARDs don’t achieve remission or low disease activity, the next step is a biologic or targeted synthetic DMARD. These are more precisely engineered medications that block specific parts of the immune system driving the inflammation.
Biologics include TNF inhibitors, which neutralize a specific inflammatory protein called tumor necrosis factor, one of the main drivers of joint destruction in RA. Other biologics target different immune pathways. Some block certain white blood cell interactions, while others neutralize a protein called interleukin-6 that fuels inflammation.
A newer option is JAK inhibitors, which are taken as pills rather than injections. These work by blocking an intracellular signaling pathway called JAK-STAT, which multiple inflammatory proteins rely on to send their signals. By intercepting this shared pathway, JAK inhibitors can suppress several inflammatory signals at once. Your rheumatologist will weigh the benefits against potential risks, including cardiovascular considerations, when deciding if these are appropriate for you.
What Treat-to-Target Means for You
Modern RA management follows a strategy called treat-to-target. Instead of simply prescribing a medication and hoping for the best, your rheumatologist sets a specific goal, usually remission or low disease activity, and adjusts treatment every three months until you reach it. This is why frequent visits matter early on.
During active disease, you can expect appointments as often as monthly. At each visit, your doctor assesses swollen and tender joints, checks blood markers of inflammation, and asks about your overall well-being. These data points feed into a composite score that tracks your disease activity over time. Once you reach sustained remission, visits can space out to every three to six months.
This structured approach means treatment isn’t static. If one medication isn’t working well enough, it gets changed or combined with another. The goal is always to reach the target as quickly as possible while minimizing side effects.
Protecting Your Joints Day to Day
Medication handles the disease process, but how you use your body matters too. Occupational therapy focuses on joint protection, a set of practical strategies for reducing stress on inflamed joints during everyday activities. The core principles are straightforward: avoid tight grips, use larger joints when possible (carrying a bag on your forearm instead of gripping it with your fingers), and don’t hold objects in one position for long periods.
Assistive devices play a big role. Jar openers, ergonomic kitchen tools, button hooks, and built-up pen grips reduce the force your hands need to exert. Working splints can support wrist and finger joints during tasks that would otherwise cause pain. These aren’t signs of giving up; they’re tools that let you stay active while protecting joints from unnecessary strain.
Exercise is also part of the picture. Flexibility and strengthening exercises help maintain range of motion and support the muscles around affected joints. Many people with RA find that regular low-impact activity, like swimming, cycling, or walking, reduces stiffness and improves energy levels. Fatigue management strategies, such as pacing activities and planning rest breaks, help you get through the day without triggering flares.
Diet and Inflammation
No diet cures RA, but what you eat can influence your overall inflammation levels. The Mediterranean diet, rich in fish, vegetables, olive oil, whole grains, and nuts, is the best-studied anti-inflammatory eating pattern. Omega-3 fatty acids from fish like salmon, mackerel, and sardines reduce C-reactive protein (CRP) and interleukin-6, two key inflammatory markers in RA.
Fiber from whole foods also lowers CRP, and interestingly, getting fiber from food works better than taking fiber supplements. Colorful fruits and vegetables containing carotenoids, the pigments that make carrots, peppers, and sweet potatoes orange and red, are particularly effective at reducing CRP levels. None of this replaces medication, but an anti-inflammatory diet can complement your treatment plan and support your overall health.
When Surgery Becomes an Option
Surgery is reserved for joints that haven’t responded to medical management. In early-stage disease where the joint itself isn’t yet destroyed but swelling persists despite medication, a procedure called synovectomy can remove the inflamed tissue lining the joint. This can be done arthroscopically, through small incisions, and provides relief by eliminating the source of ongoing inflammation in that joint.
For joints where cartilage has been destroyed and bone damage has occurred, joint replacement is the most reliable option. Knees and hips are replaced most commonly, but shoulders, elbows, and smaller joints can also be addressed. Joint replacement is always elective, but delaying it too long once it’s indicated can lead to problems. Prolonged disuse causes bone thinning and increased stiffness, which can make the surgery more complex and compromise the outcome. If your rheumatologist or orthopedic surgeon recommends replacement, having it done in a reasonable timeframe typically leads to better results.